Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

Market Cap	1.20B
Revenue (ttm)	56.97M
Net Income (ttm)	-111.06M
Shares Out	239.11M
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	98,200
Average Volume	154,680
Open	4.070
Previous Close	4.070
Day's Range	4.000 - 4.190
52-Week Range	3.500 - 14.020
Beta	-1.19
RSI	64.63
Earnings Date	May 28, 2025

About HKG:6922

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, develops, produces, and sells minimally-invasive interventional cryotherapy products in the People’s Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. Its products include Bladder Cryoablation System, a cryotherapy device for t...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 276
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6922

Financial Performance

In 2024, HKG:6922's revenue was 53.53 million, an increase of 30.72% compared to the previous year's 40.95 million. Losses were -104.37 million, 7.06% more than in 2023.

Financial numbers in CNY